Research Nester Logo.jpg
Epinephrine Market revenue to cross USD 4 Billion by 2033, says Research Nester
July 06, 2023 05:30 ET | Research Nester
New York, July 06, 2023 (GLOBE NEWSWIRE) -- The global epinephrine market is estimated to grow at a CAGR of ~12% from 2023 to 2033. The market is estimated to garner a revenue of ~USD 4 billion by...
Connected Drug Delivery Devices Market to hit USD 3.5 Billion by 2032, says Global Market Insights Inc.
April 05, 2023 06:10 ET | Global Market Insights Inc.
Selbyville, Delaware, April 05, 2023 (GLOBE NEWSWIRE) -- Connected drug delivery devices market value is anticipated to reach USD 3.5 billion by 2032, according to a new research report by Global...
Adamis Pharmaceuticals Corporation Issues Nationwide Voluntary Recall of SYMJEPI® (epinephrine) Injection for Potential Manufacturing Defect
March 21, 2022 16:05 ET | Adamis Pharmaceuticals Corporation
SAN DIEGO, March 21, 2022 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (Nasdaq: ADMP) is voluntarily recalling certain lots of SYMJEPI (epinephrine) Injection 0.15 mg (0.15 mg/0.3 mL) and...
Robert, Olivia & Merrill Debbs
Red Sneakers for Oakley Hosts Evening to Support Food Allergy Awareness at Club Colette in Palm Beach, FL
December 06, 2021 17:03 ET | Red Sneakers for Oakley
PALM BEACH, Fla., Dec. 06, 2021 (GLOBE NEWSWIRE) -- On Tuesday, November 23, Red Sneakers for Oakley hosted the sold-out Fourth Annual Fundraising Benefit at Club Colette to support food allergy...
Adamis Pharmaceuticals logo
Adamis Announces Appointment of David C. Benedicto as Chief Financial Officer and Other Events
August 24, 2021 16:05 ET | Adamis Pharmaceuticals Corporation
SAN DIEGO, Aug. 24, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced that David C. Benedicto, who has been serving as the Company’s Chief Accounting...
Adamis Pharmaceuticals logo
Adamis Pharmaceuticals Provides an Update on ZIMHI™
April 12, 2021 07:00 ET | Adamis Pharmaceuticals Corporation
SAN DIEGO, April 12, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today provided an update on the status of the company’s New Drug Application (NDA) relating to its...
Insights on the Auto-Injectors Global Market to 2026 - Featuring Antares Pharma, Mylan & Amgen Among Others
October 01, 2020 04:59 ET | Research and Markets
Dublin, Oct. 01, 2020 (GLOBE NEWSWIRE) -- The "Auto-Injectors Market Global Forecast by Regions, Application (Anaphylaxis, Multiple Sclerosis, Rheumatoid Arthritis, Others), Product Types,...
Preventing Anaphylaxis
August 01, 2019 14:06 ET | The Jackson Laboratory
Farmington, Connecticut, Aug. 01, 2019 (GLOBE NEWSWIRE) -- An antibody, known as IgE, is the culprit in allergic reactions to everything from peanuts to tree pollen. A kind of super-antibody, known...
Global Autoinjectors Market is Set to Reach USD 4.5 Billion by 2024, Growing at a CAGR of 16.9% During the Forecast Period: VynZ Research
June 03, 2019 06:18 ET | VynZ Research
NEW YORK, June 03, 2019 (GLOBE NEWSWIRE) -- The global autoinjectors market is predicted to grow at 16.9% CAGR during the forecast period with the market size reaching USD 4.5 billion by 2024. The...
Aegis is Awarded US
Aegis is Awarded US Patent for Formulation and Non-invasive Delivery of Peptide Drugs
August 15, 2018 06:00 ET | Aegis Therapeutics LLC
SAN DIEGO, Aug. 15, 2018 (GLOBE NEWSWIRE) -- Aegis Therapeutics LLC announced today that it has been awarded US Patent No. 10,046,025, providing non-invasive delivery of cyclic peptide drugs....